Subscribe
shutterstock_1086023561_-sichkarenko_com
sichkarenko.com / Shutterstock.com
14 November 2019AmericasRory O'Neill

Chinese state-owned chemical firm in fungicide patent suit

A Chinese state-owned chemical firm is suing US crop protection products company Atticus for patent infringement.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
Amendments to Chinese Patents Law for the Life Sciences
9 September 2021   Recent changes to patent law in China sees registration, review and litigation fall in line with established international IP systems, say Venable partners Keith Haddaway and Christopher Loh.
Americas
Psychedelics: from fungi and plants to patents
30 September 2021   With the significant growth of cannabinoid IP in the past few years, eyes are now on the emerging psychedelics market as the next frontier for IP protection. Gretchen Temeles of Hiller and Timothy Schlidt of Palo Santo Ventures discuss the issues.
Americas
Bayer settles fungicide trade secrets claims
23 December 2019   Bayer has dropped trade secrets claims against a former employee and rival company, which it had accused of stealing confidential information related to organic fungicides.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Asia
Amendments to Chinese Patents Law for the Life Sciences
9 September 2021   Recent changes to patent law in China sees registration, review and litigation fall in line with established international IP systems, say Venable partners Keith Haddaway and Christopher Loh.
Americas
Psychedelics: from fungi and plants to patents
30 September 2021   With the significant growth of cannabinoid IP in the past few years, eyes are now on the emerging psychedelics market as the next frontier for IP protection. Gretchen Temeles of Hiller and Timothy Schlidt of Palo Santo Ventures discuss the issues.
Americas
Bayer settles fungicide trade secrets claims
23 December 2019   Bayer has dropped trade secrets claims against a former employee and rival company, which it had accused of stealing confidential information related to organic fungicides.

More on this story

Asia
Amendments to Chinese Patents Law for the Life Sciences
9 September 2021   Recent changes to patent law in China sees registration, review and litigation fall in line with established international IP systems, say Venable partners Keith Haddaway and Christopher Loh.
Americas
Psychedelics: from fungi and plants to patents
30 September 2021   With the significant growth of cannabinoid IP in the past few years, eyes are now on the emerging psychedelics market as the next frontier for IP protection. Gretchen Temeles of Hiller and Timothy Schlidt of Palo Santo Ventures discuss the issues.
Americas
Bayer settles fungicide trade secrets claims
23 December 2019   Bayer has dropped trade secrets claims against a former employee and rival company, which it had accused of stealing confidential information related to organic fungicides.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York